Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Pathologica ; 112(4): 174-177, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-1022379

ABSTRACT

Up to now, Italy is one of the European centers with the most active Coronavirus cases with 233,836 positive cases and 33,601 total deaths as of June 3rd. During this pandemic and dramatic emergency, Italian hospitals had also to face neoplastic pathologies, that still afflict the Italian population, requiring urgent surgical and oncological treatment. In our Cancer Center Hospital, the high volume of surgical procedures have demanded an equally high volume of intraoperative pathological examinations, but also posed an additional major challenge for the safety of the staff involved. The current commentary reports our experience in the past two months (since March 9th) for a total of 1271 frozen exams from 893 suspect COVID-19 patients (31 confirmed).


Subject(s)
COVID-19 , Containment of Biohazards/standards , Intraoperative Care/standards , Pandemics , Pathology/standards , COVID-19/epidemiology , Humans , Intraoperative Care/statistics & numerical data , Italy/epidemiology , Middle Aged , Pathology/statistics & numerical data
2.
Ann Diagn Pathol ; 48: 151560, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-621789

ABSTRACT

The coronavirus disease 2019 (COVID-19) pandemic has dramatically changed the world over the past weeks, with already 8,25 million infections and 445,000 deaths worldwide, leading to an unprecedented international global effort to contain the virus and prevent its spread. The emergence of novel respiratory viruses such as the SARS-CoV-2 creates dramatic challenges to the healthcare services, including surgical pathology laboratories, despite their extensive daily experience in dealing with biological and chemical hazards. Here, we cover important aspects on the knowledge on COVID-19 gathered during the first six months of the pandemic and address relevant issues on human biological sample handling in the Anatomic Pathology laboratory in the context of COVID-19 global threat. In addition, we detail our strategy to minimize the risk of contamination upon exposure to the different biological products received in the laboratory, which can be of general interest to other laboratories worldwide. Our approach has enabled a safe work environment for laboratory staff, while ensuring the maintenance of high quality standards of the work performed. In times of uncertainty and given the lack of specific guidelines directed at Anatomic Pathology services to better deal with the global COVID-19 public-health emergency, it is essential to share with the community rigorous methodologies that will enable us to better cope with probable novel waves of COVID-19 infection and other viruses that will possibly arise in the near future.


Subject(s)
Coronavirus Infections , Infection Control/methods , Laboratories, Hospital/standards , Pandemics , Pathology, Surgical/methods , Pneumonia, Viral , Specimen Handling/methods , Betacoronavirus , COVID-19 , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Humans , Infection Control/standards , Pandemics/prevention & control , Pathology Department, Hospital/standards , Pathology, Surgical/standards , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Portugal , SARS-CoV-2 , Specimen Handling/standards
SELECTION OF CITATIONS
SEARCH DETAIL